Your browser doesn't support javascript.
loading
Evaluation of Support, a self-guided online type 1 diabetes self-management education and support web application-a mixed methods study.
Xie, Li Feng; Housni, Asmaa; Roy-Fleming, Amélie; Bandini, Aude; Delormier, Treena; Costa, Deborah Da; Brazeau, Anne-Sophie.
Afiliação
  • Xie LF; McGill University, School of Human Nutrition, Montreal, Canada.
  • Housni A; McGill University, School of Human Nutrition, Montreal, Canada.
  • Roy-Fleming A; McGill University, School of Human Nutrition, Montreal, Canada.
  • Bandini A; Université de Montréal, Department of Philosophy, Montreal, Canada.
  • Delormier T; McGill University, School of Human Nutrition, Montreal, Canada.
  • Costa DD; McGill University, Department of Medicine, Montreal, Canada.
  • Brazeau AS; Research Institute of the McGill University Health Centre, Montreal, Canada.
Digit Health ; 9: 20552076231204435, 2023.
Article em En | MEDLINE | ID: mdl-37780064
ABSTRACT

Background:

Type 1 diabetes requires making numerous daily decisions to maintain normoglycemia. Support is an evidence-based self-guided web application for type 1 diabetes diabetes self-management.

Objective:

Evaluate users' satisfaction with Support and investigate changes in self-reported frequency of-, fear of- hypoglycemia, and diabetes-related self-efficacy.

Methods:

Adults from a Quebec type 1 diabetes registry used Support. Data was collected through online surveys or extracted from the registry at 0, 6, and 12 months (number of episodes and fear of hypoglycemia). At 6 months, participants reported satisfaction with Support and diabetes-related self-efficacy. A sub-group of 16 users was interviewed about their experience. Transcripts were analyzed using inductive and deductive approaches.

Results:

In total, 207 accounts were created (35% men, 96% White, mean age and diabetes duration 49.3 ± 13.8 and 25.2 ± 14.7 years). At 6 months, the median [Q1; Q3] satisfaction was 40/49 [35; 45] with a mean decrease in hypoglycemia frequency of 0.43 episodes over 3 days (95% CI -0.86; 0.00, p = 0.051) and of -1.98 score for fear (95% CI -3.76; -0.20, p = 0.030). Half of the participants reported increased diabetes-related self-efficacy.

Conclusions:

Participants reported a high level of satisfaction with Support. Its use has the potential to facilitate hypoglycemia management and increase diabetes-related self-efficacy. Trial registration This study is registered on ClinicalTrials.gov NCT04233138.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Digit Health Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Digit Health Ano de publicação: 2023 Tipo de documento: Article